Severity
Moderate
FDA Food recall · Reported December 6, 2017
The label does not list "Sodium" in the ingredient statement.
Reese Pharmaceutical Company recalled Orange Flavor Immune Support Dietary Supplement Effervescent Tablets 10 Tablets/bottle. P… - a moderate-severity action.
Orange Flavor Immune Support Dietary Supplement Effervescent Tablets 10 Tablets/bottle. P… was recalled by Reese Pharmaceutical Company in December 6, 2017. Reason: The label does not list "Sodium" in the ingredient statement.. Check the official notice for the remedy. Verify recall #F-0409-2018 with the FDA Food before acting.
The recall
Reese Pharmaceutical Company issued this moderate-severity FDA Food recall-The label does not list "Sodium" in the ingredient statement..
Sourced from official FDA Food enforcement records. Verify recall #F-0409-2018 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Food action (record #F-0409-2018) was formally reported on December 6, 2017, with the manufacturer initiating the action on August 31, 2017. It is classified under Moderate severity (Class II), with a current status of Terminated. Reese Pharmaceutical Company is listed as the recalling firm, operating out of Cleveland, OH. Federal records list the affected scope as 610,840 units/10 tablets, a scale large enough to require multi-state distribution tracking.
The documented reason for this recall is: The label does not list "Sodium" in the ingredient statement. Distribution data in the federal record shows the product reached: Product was shipped to the following states: AL, AR, AZ, CA, CO, CT, FL, GA, HI, IA, ID, IL, IN, KY, LA, MA, MD, ME, MI, MN, MO, MS, NC, NE, NJ, NY, OH, OK, OR, PA, SC, SD, TN, TX, UT, VA, WA, WI, WV & WY.. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 1 from FDA Food - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 14,287 drugs & medications recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Moderate
Affected scope
610,840 units/10 tablets
Related Recalls
6
1 from same agency
Orange Flavor Immune Support Dietary Supplement Effervescent Tablets 10 Tablets/bottle. Product is sold under the following brand names: Best Choice UPC 0 70038 60863 9 & UPC 0 70038 60863 9; Discount Drug Mart UPC 0 93351 00909 9; Freds Mart UPC 0 84579 12451 0; Good Neighbor Pharmacy UPC 0 87701 40672 0; Health Accents UPC 7 25439 95738 0; Health Mart UPC 0 52569 14073 4; Hyvee UPC 0 75450 06187 1; Kinray Preferred Plus UPC 0 23513 81512 1; Leader UPC 0 96295 13167 3 & UPC 0 96295 12239 8; Live Better UPC 0 41310 62997 0; Meijer UPC 7 08820 15072 0; Premier Value UPC 8 40986 01982 1; QC UPC 6 35515 95513 4; Reese UPC 0 23513 81512 1; Rite Aid UPC 0 11822 45092 8; Select Brand UPC 0 15127 02433 4; Shopko UPC 4 00125 10186 4; ShopRite UPC 0 41190 22785 3; Top Care UPC 0 36800 38123 0 & UPC 0 36800 38123 0; Western Family UPC 0 15400 12656 4 & Winco UPC 0 70552 24154 1.
The label does not list "Sodium" in the ingredient statement.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Moderate (Class II) |
| Status | Terminated |
| Recall number | F-0409-2018 |
| Date reported | December 6, 2017 |
| Date initiated | August 31, 2017 |
| Recalling firm | Reese Pharmaceutical Company |
| Firm location | Cleveland, OH |
| Affected scope | 610,840 units/10 tablets |
| Distribution | Product was shipped to the following states: AL, AR, AZ, CA, CO, CT, FL, GA, HI, IA, ID, IL, IN, KY, LA, MA, MD, ME, MI, MN, MO, MS, NC, NE, NJ, NY, OH, OK, OR, PA, SC, SD, TN, TX, UT, VA, WA, WI, WV & WY. |
Profile values are sourced directly from the official FDA Food enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Food record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
AbbVie Inc. · 2026-06-03
Llorens Pharmaceuticals International Division, Inc. · 2026-05-27
Safecor Health, LLC · 2026-05-27
IntegraDose Compounding Services LLC · 2026-05-27
Lupin Pharmaceuticals Inc. · 2026-05-27
Compare this recall with PRED MILD, prednisolone acetate ophthalmic suspension, USP,… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Food, reported December 6, 2017. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.